1193705-03-1

Basic information

• Product Name: [7-(methylsulfonyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl 4-methylbenzenesulfonate
• Synonyms: [7-(methylsulfonyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl 4-methylbenzenesulfonate
• CAS NO: 1193705-03-1
• Molecular Weight: 398.458
• Mol File: 1193705-03-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [7-(methylsulfonyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl 4-methylbenzenesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: [7-(methylsulfonyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl 4-methylbenzenesulfonate(1193705-03-1)
• EPA Substance Registry System: [7-(methylsulfonyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl 4-methylbenzenesulfonate(1193705-03-1)

Safety Data

• Hazardous Substances Data: 1193705-03-1(Hazardous Substances Data)

Upstream product

• 1761-61-1 5-bromosalicyclaldehyde 
• 1193708-67-6 5-bromo-2-(oxiran-2-ylmethoxy)phenyl formate 
• 280752-79-6 (7-bromo-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanol 
• 1193708-69-8 (6-methylsulfonyl-2,3-dihydro-1,4-benzodioxin-3-yl)methanol 
• 98-59-9 p-toluenesulfonyl chloride 

Relevant articles and documents

MODULATORS OF DOPAMINE NEUROTRANSMISSION

The present invention relates to novel 1-(2,3-dihydro-1,4-benzodioxin-2-yl)- methanamine derivatives, useful as modulators of dopamine neurotransmission, and more specifically as dopaminergic stabilizers. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.